SCHEMBL4200145

SCHEMBL4200145

Cc1nc(-c2cccc(S(=O)(=O)Nc3ccccc3CN[C@@H](C)CC3CCCC3)c2)cs1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 1/20 0.55
HTT P42858 5/20 0.48
ALDH1A1 P00352 5/20 0.48
HPGD P15428 2/20 0.48
MAPT P10636 5/20 0.46
LMNA P02545 4/20 0.46
KDM4E B2RXH2 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
GAA P10253 3/20 0.43
GFER P55789 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
USP2 O75604 3/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
ALOX15 P16050 1/20 0.41
USP30 Q70CQ3 1/20 0.41
PKM P14618 1/20 0.40
PRMT6 Q96LA8 1/20 0.38
KDM1A O60341 1/20 0.37
MAOA P21397 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4190019 0.99 PTGES2 (0.54) PTGES2HTTALDH1A1HPGDMAPT
SCHEMBL4201724 0.99 PTGES2 (0.54) PTGES2HTTALDH1A1HPGDMAPT
SCHEMBL4197986 0.83 KDM4E (0.47) PTGES2ALDH1A1MAPTKDM4ENPSR1
SCHEMBL4193456 0.83 KDM4E (0.46) PTGES2ALDH1A1HPGDMAPTKDM4E
SCHEMBL14344104 0.80 BRD4 (0.52) KDM4EPKM
SCHEMBL12050344 0.79 KDM4E (0.55) PTGES2HTTALDH1A1MAPTLMNA
SCHEMBL4194146 0.79 PKM (0.46) ALDH1A1MAPTLMNAKDM4EPKM
SCHEMBL4190907 0.78 PKM (0.40) HTTALDH1A1HPGDMAPTLMNA
SCHEMBL4192953 0.78 MAPT (0.47) PTGES2HTTALDH1A1HPGDMAPT
SCHEMBL4189913 0.77 KDM4E (0.45) HTTALDH1A1MAPTLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 PTGES2 4392/4885HTT 390/4885ALDH1A1 2744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.